Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 38.72B P/E 24.57 EPS this Y 12.20% Ern Qtrly Grth -3.40%
Income 1.85B Forward P/E 14.97 EPS next Y 9.40% 50D Avg Chg 4.00%
Sales 276.54B PEG 1.74 EPS past 5Y 14.63% 200D Avg Chg 14.00%
Dividend 1.00% Price/Book 42.01 EPS next 5Y 9.34% 52W High Chg -2.00%
Recommedations 2.10 Quick Ratio 0.50 Shares Outstanding 196.93M 52W Low Chg 42.00%
Insider Own 13.49% ROA 2.88% Shares Float 174.22M Beta 0.47
Inst Own 88.54% ROE 213.15% Shares Shorted/Prior 8.53M/8.16M Price 191.43
Gross Margin 3.40% Profit Margin 0.67% Avg. Volume 1,383,235 Target Price 258.07
Oper. Margin 1.26% Earnings Date Jul 31 Volume 1,846,171 Change 1.23%
About AmerisourceBergen Corporation

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

AmerisourceBergen Corporation News
05/24/24 After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
05/22/24 Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
05/04/24 There's A Lot To Like About Cencora's (NYSE:COR) Upcoming US$0.51 Dividend
05/02/24 Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
05/02/24 Cencora Second Quarter 2024 Earnings: Misses Expectations
05/01/24 Cencora Reports Fiscal 2024 Second Quarter Results
04/15/24 Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
04/15/24 Here's Why Cencora (COR) is a Strong Value Stock
04/05/24 Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
08:40 AM Are Medical Stocks Lagging Artivion (AORT) This Year?
03/27/24 Why Cencora (COR) is a Top Growth Stock for the Long-Term
03/12/24 Cencora Announces Leadership Succession Plan
02/23/24 Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
02/07/24 Walgreens Boots pockets $992 million after cutting Cencora stake for third time
02/07/24 Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
02/07/24 Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
02/07/24 Cencora Closes $500 Million Senior Notes Offering
02/05/24 Cencora Prices $500 Million 5.125% Senior Notes Due 2034
02/04/24 Companies test out different ways to talk about ESG without saying 'ESG'
01/31/24 Cencora Reports Fiscal 2024 First Quarter Results
COR Chatroom

User Image hingfdiuh Posted - 1 day ago

@juzbeachy $WBA doesn’t break out health segment by asset but even if they did you wouldn’t see any $BTSG hit the income statement because it is not wholly owned. You would want to look in the ”Equity Method Investment” section of their filing (below $COR) to see the value of their investment in $BTSG (plus others). As of Feb 29 the ”other” investments was valued at $1.07B. Walgreens owns 34.86 million shares of $BTSG so at close on Feb 29 stock price of $8.99 = $313.39M. As of Friday the value would be 34.86M x $11.32 = $394.62M. If $BTSG reaches $20 like some analysts think then $WBA stake would be worth substantially more at $697.2M

User Image Brnxbmr Posted - 4 days ago

$COR https://techcrunch.com/2024/05/24/cencora-americans-health-data-stolen-breach-cyberattack/?guccounter=1

User Image tradingtwenty Posted - 5 days ago

Top 5 oversold stocks that have trended in the past 24 hours: $COUR 17.24 🔥 $LULU 19.99 $FWRD 21.73 $XP 22.23 $COR 22.95 Values range from 0 to 100, where 30 or below is oversold and 70 or above overbought. Link: https://tradingtwenty.com/dashboard/trending/past

User Image hingfdiuh Posted - 5 days ago

$WBA sells $400M of $COR stock which equates to 2.78% of $WBA market cap as of close today

User Image DonCorleone77 Posted - 5 days ago

$COR Cencora raises FY24 adjusted EPS view to $13.35-$13.55 from $13.30-$13.50 FY24 consensus $13.44. Cencora is also raising its fiscal year 2024 adjusted diluted earnings per share guidance to $13.35-$13.55, up from the previous range of $13.30-$13.50, to reflect a lower weighted average diluted share count, partially offset by higher net interest expense due to lower investment balances as a result of cash being used for share repurchases. This transaction is an example of the company's opportunistic approach to share repurchases and the company will now have completed approximately $550M of share repurchases in the month of May.

User Image DonCorleone77 Posted - 5 days ago

$COR $WBA Cencora to repurchase $400M in shares from Walgreens Boots Alliance Cencora (COR) announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance (WBA) in the amount of approximately $400M in a private transaction.

User Image Stock_Titan Posted - 5 days ago

$COR Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance https://www.stocktitan.net/news/COR/cencora-announces-common-share-repurchase-from-walgreens-boots-tj985xyoeq7w.html

User Image iQuicky Posted - 2 weeks ago

$COR Time to go back up

User Image Aigner_Andreas Posted - 3 weeks ago

TF SELL $COR at 229.2 : 233.49 BigCap 98% Shp 2.13 S 1.31 N 0.63 RSI 32.79% SRSI 0% ADXR 21.75 #stocks #trading #finance #market

User Image Cutlass Posted - 3 weeks ago

$COR 8% inflation and they miss rev - 👀

User Image epsguid Posted - 3 weeks ago

$COR reported earnings of $3.80, consensus was $3.65, Earnings Whisper was $3.75 via @eWhispers #whisperbeat http://eps.sh/d/cor

User Image DonCorleone77 Posted - 3 weeks ago

$COR Cencora raises FY24 adjusted EPS view to $13.30-$13.50 from $13.25-$13.50 FY24 consensus $13.45.

User Image DonCorleone77 Posted - 3 weeks ago

$COR Cencora reports Q2 adjusted EPS $3.80, consensus $3.69 Reports Q2 revenue $68.4B, consensus $70.65B. "Cencora's critical role at the center of healthcare and the pharmaceutical supply chain was on full display during the quarter as our purpose-driven team members' solutions-oriented mindset helped our customers navigate through complexity and uncertainty," said Steven H. Collis, Chairman, President, and Chief Executive Officer of Cencora. "Our strong second quarter results and updated full-year guidance, reflect the importance of the value we deliver across our footprint," continued Mr. Collis. "As we move into the second half of our fiscal year, our focus on creating a best-in-class customer experience, embracing innovation and investing in our infrastructure will allow us to continue to further our pharmaceutical-centric strategy and drive differentiated value for our customers, partners and all our stakeholders."

User Image Stock_Titan Posted - 3 weeks ago

$COR Cencora Reports Fiscal 2024 Second Quarter Results https://www.stocktitan.net/news/COR/cencora-reports-fiscal-2024-second-quarter-rzzkphh2fr35.html

User Image ihavetonsils Posted - 04/30/24

$COR

User Image insiderbuyingselling Posted - 1 month ago

$COR new insider selling: 57564 shares. http://insiderbuyingselling.com/?t=COR

User Image Stock_Titan Posted - 1 month ago

$COR Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release https://www.stocktitan.net/news/COR/cencora-announces-date-and-time-for-second-quarter-fiscal-2024-qyv09nx40pz1.html

User Image Stocksrunner Posted - 1 month ago

$COR has been on a tear, surging to a new 52-week high of $246.75 in the last session. The stock is up 4.7% over the past month and has gained 19.7% so far this year. Traders are now assessing whether this hot streak has more room to run or if it's time to cash out near these 52-week highs. $COR's momentum has been impressive, but prudent risk management is key. https://stocksrunner.com/symbol/COR

User Image Daniel3303 Posted - 1 month ago

$WBA this is either a bot spamming or someone who doesn't know anything about the company. They could just sell all the $COR shares and pay 90% of the total debt. There is no way they are going bankrupt in the near term.

User Image crtlabz Posted - 2 months ago

$COR

User Image crtlabz Posted - 2 months ago

$COR

User Image StockConsultant Posted - 2 months ago

$COR Cencora nice flat top breakout, from Stocks To Watch list

User Image Stocksrunner Posted - 2 months ago

🚀📈 52-Week High Alert: 🔥 $COR Hit a fresh 52-week high of $240.86 on Mar 18, 2024, before closing slightly lower. 🔥 $DIS Traversing new highs, with shares hitting a 52-week high earlier this month. Up 26% in 2024, Disney's performance is captivating. 🔥 $TXT Shares on the move, up 8.7% over the past month. Recently hit a 52-week high of $93.71. Stay tuned for market insights!

User Image Stocksrunner Posted - 2 months ago

📈 Tuesday Traders Watchlist 📊 $NVDA Stock shows 40% Upside Potential, near All-Time High. Analysts ponder if it's a Buy. $MTEM Sector presents Oversold Opportunities. RSI indicates potential short-term gains. Keep an eye on Molecular Templates, recent update shook stock. $TXT hitting Fresh Highs. Momentum strong, up 8.7% past month. Watch for further gains. $COR also scaling New Highs. Strong performance, up 16.5% YTD. What's next for this soaring stock?

User Image Doozio Posted - 2 months ago

$COR they are still SKWD while it’s sitting nice n tight huckleberry riding in 🧠⏰

User Image crtlabz Posted - 2 months ago

$COR holding up well

User Image AnchorsAweigh Posted - 2 months ago

$COR getting super tight

User Image Stock_Titan Posted - 2 months ago

$COR Cencora Announces Leadership Succession Plan https://www.stocktitan.net/news/COR/cencora-announces-leadership-succession-gnjek3g017i0.html

User Image StockConsultant Posted - 2 months ago

$COR Cencora stock narrow range breakout watch above 239.65 , see https://stockconsultant.com/?COR

User Image crtlabz Posted - 2 months ago

$COR strong week

Analyst Ratings
Baird Outperform May 2, 24
Citigroup Buy Apr 30, 24
Leerink Partners Outperform Feb 26, 24
Mizuho Neutral Feb 5, 24
Barclays Overweight Jan 3, 24
Wells Fargo Equal-Weight Dec 14, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
GREENBERG LON R Director Director Jan 15 Option 219.43 1,340 294,036 26,219 01/17/24
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Nov 14 Sell 197.63 25,000 4,940,750 331,573 11/15/23
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Nov 14 Option 77.53 25,000 1,938,250 356,573 11/15/23
Cleary James F Chief Financial Offi.. Chief Financial Officer Nov 13 Option 77.53 38,136 2,956,684 139,762 11/15/23
Donato Leslie E EVP & Chief Strategy.. EVP & Chief Strategy Officer Nov 13 Sell 197.6 3,387 669,271 11,919 11/15/23
Donato Leslie E EVP & Chief Strategy.. EVP & Chief Strategy Officer Nov 13 Option 86.09 3,387 291,587 15,306 11/15/23
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Aug 08 Sell 186.19 10,499 1,954,809 257,967 08/09/23
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Aug 08 Option 77.53 10,499 813,987 268,466 08/09/23
Walgreens Boots Alliance, Inc. 10% Owner 10% Owner Aug 03 Sell 189.271 1,320,858 250,000,115 31,769,546 08/07/23
Walgreens Boots Alliance, Inc. 10% Owner 10% Owner Jun 15 Sell 181.17 275,984 50,000,021 33,090,404 06/20/23
Walgreens Boots Alliance, Inc. 10% Owner 10% Owner May 11 Sell 170.77 292,792 50,000,090 33,366,388 05/15/23
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Jan 17 Sell 164.28 10,499 1,724,776 257,967 01/19/23
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Jan 17 Option 77.53 10,499 813,987 268,466 01/19/23
Clark Gina Executive Vice Presi.. Executive Vice President Dec 12 Sell 166.3 392 65,190 28,657 12/14/22
Walgreens Boots Alliance, Inc. 10% Owner 10% Owner Dec 08 Sell 165.08 5,961,534 984,130,033 33,659,180 12/12/22
Walgreens Boots Alliance, Inc. 10% Owner 10% Owner Nov 07 Sell 154.60 13,234,153 2,046,000,054 39,629,714 11/09/22
Mauch Robert P. Executive Vice Presi.. Executive Vice President & COO Nov 04 Sell 160 21,802 3,488,320 20,197 11/04/22
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Aug 09 Option 75.61 11,480 868,003 216,658 08/11/22
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Aug 09 Sell 144.25 11,480 1,655,990 205,178 08/11/22
Walgreens Boots Alliance, Inc. 10% Owner 10% Owner May 11 Sell 150.00 6,000,000 900,000,000 52,854,867 05/13/22
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO May 10 Option 75.61 11,480 868,003 216,658 05/12/22
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO May 10 Sell 159.47 11,480 1,830,716 205,178 05/12/22
Clark Gina Executive Vice Presi.. Executive Vice President Mar 28 Sell 153.71 43,704 6,717,742 15,814 03/30/22
Clark Gina Executive Vice Presi.. Executive Vice President Mar 28 Option 75.61 29,520 2,232,007 59,518 03/30/22
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Mar 08 Option 75.61 11,480 868,003 216,658 03/09/22
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Mar 08 Sell 144.97 11,480 1,664,256 205,178 03/09/22
Mauch Robert P. Executive Vice Presi.. Executive Vice President Feb 01 Option 77.53 44,492 3,449,465 86,491 02/02/22
Mauch Robert P. Executive Vice Presi.. Executive Vice President Feb 01 Sell 137.04 44,492 6,097,184 41,999 02/02/22
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Jan 11 Option 86.93 24,264 2,109,270 229,442 01/13/22
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Jan 11 Sell 136.07 24,264 3,301,602 205,178 01/13/22
Clark Gina Executive Vice Presi.. Executive Vice President Nov 12 Option 98.24 16,027 1,574,492 35,218 11/15/21
Clark Gina Executive Vice Presi.. Executive Vice President Nov 12 Sell 125.83 16,027 2,016,677 28,358 11/15/21
Cleary James F Chief Financial Offi.. Chief Financial Officer Apr 21 Option 98.76 24,182 2,388,214 50,647 04/21/21
Krikorian Lazarus SVP & Chief Accounti.. SVP & Chief Accounting Officer Mar 09 Sell 108.48 16,236 1,761,281 14,815 03/09/21
Krikorian Lazarus SVP & Chief Accounti.. SVP & Chief Accounting Officer Mar 09 Option 75.61 16,236 1,227,604 31,051 03/09/21
McGee Henry Wadsworth III Director Director Mar 08 Sell 105.01 5,801 609,163 10,901 03/08/21
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Feb 11 Option 88.71 1,419 125,879 199,476 02/11/21
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Feb 11 Sell 108.08 1,419 153,366 198,057 02/11/21
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Feb 09 Option 88.71 74,651 6,622,290 198,757 02/09/21
COLLIS STEVEN H Chairman, President.. Chairman, President & CEO Feb 09 Sell 110.22 84,651 9,330,233 198,057 02/09/21
Chou John G. Executive Vice Presi.. Executive Vice President Nov 10 Option 68.49 5,602 383,681 57,397 11/10/20
Chou John G. Executive Vice Presi.. Executive Vice President Nov 10 Sell 108.42 5,602 607,369 51,795 11/10/20
Clark Gina Executive Vice Presi.. Executive Vice President Sep 28 Option 88.71 2,479 219,912 17,292 09/28/20
Clark Gina Executive Vice Presi.. Executive Vice President Sep 28 Sell 94.2 3,097 291,737 14,813 09/28/20
Chou John G. Executive Vice Presi.. Executive Vice President Sep 16 Option 68.49 5,602 383,681 57,397 09/16/20
Chou John G. Executive Vice Presi.. Executive Vice President Sep 16 Sell 94.88 5,602 531,518 51,795 09/16/20